These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32376441)

  • 1. What's new in the field of phospholipid vesicular nanocarriers for skin drug delivery.
    Lai F; Caddeo C; Manca ML; Manconi M; Sinico C; Fadda AM
    Int J Pharm; 2020 Jun; 583():119398. PubMed ID: 32376441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
    Sala M; Diab R; Elaissari A; Fessi H
    Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
    Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
    Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties.
    Natsheh H; Touitou E
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32605117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes and skin: from drug delivery to model membranes.
    El Maghraby GM; Barry BW; Williams AC
    Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery.
    Khan NR; Harun MS; Nawaz A; Harjoh N; Wong TW
    Curr Pharm Des; 2015; 21(20):2848-66. PubMed ID: 25925113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery.
    Akl MA; Eldeen MA; Kassem AM
    AAPS PharmSciTech; 2024 Aug; 25(6):184. PubMed ID: 39138693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
    Sharma G; Goyal H; Thakur K; Raza K; Katare OP
    Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfersomes: self-optimizing carriers for bioactives.
    Rai K; Gupta Y; Jain A; Jain SK
    PDA J Pharm Sci Technol; 2008; 62(5):362-79. PubMed ID: 19055232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
    Mura S; Manconi M; Sinico C; Valenti D; Fadda AM
    Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization.
    Jafari A; Daneshamouz S; Ghasemiyeh P; Mohammadi-Samani S
    J Liposome Res; 2023 Mar; 33(1):34-52. PubMed ID: 35695714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid vesicles for skin delivery of drugs: reviewing three decades of research.
    Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
    Int J Pharm; 2007 Mar; 332(1-2):1-16. PubMed ID: 17222523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs).
    Souto EB; Macedo AS; Dias-Ferreira J; Cano A; Zielińska A; Matos CM
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin.
    El Maghraby GM; Williams AC
    Expert Opin Drug Deliv; 2009 Feb; 6(2):149-63. PubMed ID: 19239387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
    Zorec B; Zupančič Š; Kristl J; Pavšelj N
    Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation.
    Akhtar N; Varma A; Pathak K
    Curr Clin Pharmacol; 2016; 11(3):168-190. PubMed ID: 27526697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus.
    Mbah CC; Builders PF; Attama AA
    Expert Opin Drug Deliv; 2014 Jan; 11(1):45-59. PubMed ID: 24294974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.